GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (OTCPK:SEMHF) » Definitions » Asset Impairment Charge

SEMHF (Siemens Healthineers AG) Asset Impairment Charge : $0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Asset Impairment Charge?

Siemens Healthineers AG's Asset Impairment Charge for the three months ended in Mar. 2025 was $0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was $0 Mil.


Siemens Healthineers AG Asset Impairment Charge Historical Data

The historical data trend for Siemens Healthineers AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Asset Impairment Charge Chart

Siemens Healthineers AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Siemens Healthineers AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Siemens Healthineers AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.


Siemens Healthineers AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG Business Description

Address
Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

From GuruFocus

Q2 2021 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2020 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Siemens Healthineers AG Earnings Call Transcript

By GuruFocus Research 02-14-2024